GO
Loading...

Roche Holding AG

More

  • The biotech drug lebrikizumab, which was developed by Roche Holding's Genentech unit, was tested at three doses in patients whose asthma was not sufficiently controlled even with high-dose, inhaled corticosteroids and a second asthma-controlling therapy.

  • COLUMN-Finding nooks of growth in a sluggish Europe Monday, 3 Mar 2014 | 12:27 PM ET

    CHICAGO, March 3- While the euro zone presents the unalluring face of sluggish growth, that doesn't mean it should be neglected. The reason for the negativity stems from concerns over conflict in Ukraine and reported euro zone growth at 0.3 percent in the fourth quarter.

  • DIARY-U.S. FDA advisory meetings through April 1 Friday, 21 Feb 2014 | 12:23 PM ET

    For more information on the FDA's Advisory Committee meetings, see: http://www.fda.gov/AdvisoryCommittees/Calendar/default. htm. LOCATION: College Park Holiday Inn, Ballroom, 10000 Baltimore Ave., College Park, Md..

  • Asian shares mostly higher, Nikkei rallies 3% Friday, 21 Feb 2014 | 5:51 AM ET

    An upbeat handover from Wall Street on Thursday inspired gains in most Asian shares on Friday.

  • *Market upbeat as Wall Street shrugs off weak China survey. TOKYO, Feb 21- Japan's Nikkei average jumped more than 2 percent on Friday, recouping most of the previous day's losses, as investors took heart from gains on Wall Street after a reading on U.S. manufacturing hit its highest in nearly four years.

  • Feb 11- An advisory panel to the U.S. Food and Drug Administration said on Tuesday that available evidence does not prove that the painkiller naproxen, sold under the brand names Aleve and Naprosyn, carries a lower cardiac risk than rival products.

  • Feb 11- An advisory panel to the U.S. Food and Drug Administration voted on Tuesday that there is not enough evidence to show conclusively that the painkiller naproxen carries a lower cardiac risk than other popular products.

  • Is Switzerland closed for business? Monday, 10 Feb 2014 | 4:37 AM ET
    Geneva, Switzerland

    Sunday's vote in Switzerland has raised fears that the measure is the latest in a long list of reforms that could curb the country's business-friendly environment.

  • Swiss vote to set limits on immigration from EU Monday, 10 Feb 2014 | 1:21 AM ET

    Swiss voters on Sunday narrowly backed proposals to reintroduce immigration quotas with the European Union, Swiss television reported.

  • MUMBAI/ LONDON, Feb 6- Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.

  • Roche 2013 sales fall but CEO confident Thursday, 30 Jan 2014 | 12:00 AM ET

    Global healthcare company Roche is confident of growth in emerging markets despite the economic slowdown.

  • Children's top flu medicine in short supply in U.S. Thursday, 9 Jan 2014 | 5:56 PM ET

    But the delay in packaging the liquid version has not affected supplies of regular Tamiflu, said the Roche unit that makes the medication.

  • European stocks close lower; Swiss stocks weigh Tuesday, 10 Dec 2013 | 11:50 AM ET

    European equities closed lower on Tuesday as investors remained cautious over the timing of the Fed's reduction of its stimulus program.

  • GSK's China sales topple on bribery scandal Wednesday, 23 Oct 2013 | 7:38 AM ET

    GlaxoSmithKline's pharmaceutical and vaccine sales to China tumbled 61 percent in the third quarter, with the drugmaker hit by an ongoing bribery investigation.

  • EU stocks close narrowly higher after debt deal Thursday, 17 Oct 2013 | 12:05 PM ET

    European equities closed narrowly higher on Thursday, with investors underwhelmed by U.S. lawmakers finally reaching a deal to lift the country's borrowing limit.

  • Roche looking to emerging markets for growth: CEO Thursday, 17 Oct 2013 | 1:21 AM ET

    Emerging markets still offer room for growth, Roche's CEO told CNBC after the pharma posted an 8 percent increase in third-quarter sales.

  • Now that that's over with, markets to focus on this Wednesday, 16 Oct 2013 | 10:17 PM ET

    With Washington's debt battle over, markets will quickly shift focus to earnings and how much the government shutdown actually impacted the economy.

  • Why Roche is launching a new investment plan     Monday, 14 Oct 2013 | 11:35 AM ET

    Andrew Weiss, head of pharma and biotech research at Vontobel, says Roche's plan reflects the Swiss pharmaceutical giant's strong pipeline.

  • Lufthansa signs record deal with Boeing, Airbus Thursday, 19 Sep 2013 | 11:58 AM ET

    German airline Deutsche Lufthansa announced its largest-ever aircraft order on Thursday, worth 14 billion euros ($19.0 billion).

  • Verizon prices record $49 billion bond sale Wednesday, 11 Sep 2013 | 2:05 PM ET

    Verizon Communications priced a massive bond sale on Wednesday, offering $49 billion worth of debt.